FTR #1156 Bio-Psy-Op Apocalypse Now, Part 16: An Ounce of Prevention . . . .
In past programs, we have briefly noted that military and [ostensibly] civilian programs officially involved with “epidemic prevention” might conceal clandestine biological warfare applications designed to create epidemics.
This program further develops that inquiry
The official distinction between “offensive” and “defensive” biological warfare research is academic.
In that context, one should note that the official title of Unit 731, the notorious Japanese biological warfare unit was “the Epidemic Prevention and Water Purification Department of the Kwantung Army.”
Noteworthy in that general context is the observation by Jonathan King (professor of molecular biology at MIT), that Pentagon research into the application of genetic engineering to biological warfare could be masked as vaccine research, which sounds “defensive.”
In FTR #1130, we noted the role of four-star general Gustave Perna in Trump’s “Operation Warp Speed,” instituted by General Mark Milley, Chairman of the Joint Chiefs of Staff.
Whether the program serves as cover for military research seems a reasonable question to ask, under the circumstances.
In our last program, we weighed New York Times columnist Charles Blow’s thoughts about a white-supremacist minority grouped around the GOP. Blow saw those interests working to preserve their privilege in a number of respects.
This program asks, in effect, if the global equivalent of Blow’s malefactors might be doing something similar with the Covid-19 “op” and related, overlapping clandestine operations. How might the interests we saw in FTR #1128
Selected excerpts of a Whitney Webb article provide insight into the possible offensive nature of programs ostensibly aimed at preventing epidemics. Like Unit 731 (see above), “Epidemic Prevention” may well be masking “epidemic creation.”
In connection with that possibility, the DARPA focus on gene-driving technology is frightening and fraught with devastating possibilities.
Whether or not gene-driving impacts DARPA assisted Covid-19 vaccine development by Moderna and Inovio, the Pentagon underwriting of these firms is of concern.
Some interesting points raised by Dr. Daniel R. Lucey are particularly important in light of the information we have developed in the past about gain of function experiments.
Lucey’s points of inquiry–although not discussed in this article–are particularly important when considered in conjunction with the joint U.S./Chinese program to investigate bat-borne coronaviruses, a program whose American funding apparatus involved USAID, a frequent front for CIA operations.
The gain of function experiments we discussed in FTR #‘s 1116, 1117 and 1121 involving adapting the H5N1 avian flu virus to ferrets is worth contemplating in the context of information indicating that the SARS Cov‑2 virus is particularly infective for ferrets.
Was part of the modified H5N1 flu virus adapted to SARS Cov‑2?
A key factor spurring our suspicion concerning genetic-engineering of one or more variant of the Covid-19 virus concerns a 2015 Gain-of-Function experiment. This should answer Dr. Lucey’s query.
“. . . . Ralph Baric, an infectious-disease researcher at the University of North Carolina at Chapel Hill, last week (November 9) published a study on his team’s efforts to engineer a virus with the surface protein of the SHC014 coronavirus, found in horseshoe bats in China, and the backbone of one that causes human-like severe acute respiratory syndrome (SARS) in mice. The hybrid virus could infect human airway cells and caused disease in mice. . . . The results demonstrate the ability of the SHC014 surface protein to bind and infect human cells, validating concerns that this virus—or other coronaviruses found in bat species—may be capable of making the leap to people without first evolving in an intermediate host, Nature reported . . . .”
Critics have flagged Gain-Of-Function research as dangerous. Proponents are not dissuaded, including Peter Daszak. “. . . . But Baric and others argued the study’s importance. ‘[The results] move this virus from a candidate emerging pathogen to a clear and present danger,’ Peter Daszak, president of the EcoHealth Alliance, which samples viruses from animals and people in emerging-diseases hotspots across the globe, told Nature. . . .”
Of more than passing interest is the disclosure that the project on bat-borne coronaviruses conducted in the Wuhan laboratory was a joint U.S./Chinese project, and that Ralph Baric was a key American partner in the project.
This is the undertaking about which we have reported and discussed extensively in the past! ” . . . . One of Dr Shi’s co-authors on that paper, Professor Ralph Baric from North Carolina University, said in an interview with ‘Science Daily’ at the time: ‘This virus is highly pathogenic and treatments developed against the original SARS virus in 2002 and the ZMapp drugs used to fight ebola fail to neutralise and control this particular virus.’ . . . .”
We note that the WIV project co-funded by USAID involved genetic manipulation of bat-borne coronaviruses.
” . . . . Now Dr Richard Ebright, an infectious disease expert at Rutgers University (USA), has alerted the public to evidence that WIV and US-based researchers were genetically engineering bat viruses to investigate their ability to infect humans, using commonly used methods that leave no sign or signature of human manipulation. Ebright flagged up a scientific paper published in 2017 by WIV scientists, including Shi Zhengli, the virologist leading the research into bat coronaviruses, working in collaboration with Peter Daszak of the US-based EcoHealth Alliance. Funding was shared between Chinese and US institutions, the latter including the US National Institutes of Health and USAID. The researchers report having conducted virus infectivity experiments where genetic material is combined from different varieties of SARS-related coronaviruses to form novel ‘chimeric’ versions. . . .”
In May, the Trump administration terminated the funding for the project. A key point of analysis was set forth by Dr. Christine Johnson: ” . . . . Virus samples in labs are almost never still infectious, after being frozen in nitrogen during the collection process and then inactivated in the lab to preserve their genetic sequence. . . .
FTR #1155 Bio-Psy-Op Apocalypse, Now Part 15: Covid-19 Updates, Part 4
Continuing coverage of the Covid-19 pandemic–almost certainly a biological warfare project crafted by the U.S. national security establishment–the broadcast centers on the dual function of “epidemic prevention” and “epidemic causation” and supplementing a Charles Blow op-ed piece in “The New York Times.”
Building on the concept (discussed many times in the past) that the difference between “offensive” and “defensive” biological warfare research is academic, we note that credentialed observers have cited Pentagon “vaccine” research as a cover for offensive BW research. In addition, we observe that numerous, overlapping programs ostensibly aimed at “preventing” epidemics may well mask efforts at generating them.
One of the most notorious and advanced biological warfare programs in history was Japan’s Unit 731, melded into the U.S. biological warfare program at the end of World War II. The program was officially labeled: “the Epidemic Prevention and Water Purification Department of the Kwantung Army.”
Revisiting the consummately important Whitney Webb article about Pentagon research into bat-borne coronaviruses, we note:
1.–The DARPA research is ostensibly aimed at preventing pandemics but–very possibly–masking preparations for offensive biological warfare projects.
2.–The Pentagon is researching “gene-driving”–a biotechnological development that can permanently alter the genetic makeup of entire population groups and lead to the extinction of other groups.
3.–The Pentagon research is heavily networked with companies using DNA and mRNA vaccines for Covid-19.
The fundamental point of analysis and discussion in this program, and the next, concerns the use of “Epidemic Prevention” to mask exterminationist offensive biological warfare programs to entrench, expand or introduce a white-supremacist/First World Domination dynamic in the U.S. and abroad.
Is this the legacy of Unit 731, nominally an “Epidemic Prevention” program?!
A column by Charles Blow correctly notes that the right-wing is working to “lock-in” power. Blow’s observation is far more important when the context is expanded to include the full-court press against China and the effects of Covid-19 in the U.S.
Not a superpower at this point in time, China has made rapid, remarkable progress:
1.–In 1981, 88% of the Chinese population lived in poverty. That was down to 0.7% in 2015.
2.–The Chinese middle class was 4% of their population in 2002. By 2018, that was up to 31% of their population.
3.–In 2000, just 2% of the Chinese population had access to the internet. That was up to 29% by 2009.
With the stunning progress made by China, in combination with their enormous population, the nation will be a major power in the future.
Because they are not white and because their system of state capitalism is at loggerheads with the neo-liberal dogma to which the West is enthrall, that country will be brought to heel. The anti-China push by the West is fundamentally white supremacist in nature.
Pursuant to discussion of the Charles Blow column, Mr. Emory reads the headlines and bylines from a number of New York Times articles underscoring how the pandemic is working against two trends that Blow cites as inimical to continued GOP control.
The pandemic is badly damaging the fortunes of urban centers and education, both at the public school and university levels. In that regard, the pandemic is accomplishing what the Charles Blow column enunciates.
Some interesting points raised by Dr. Daniel R. Lucey are particularly important in light of the information we have developed in the past about gain of function experiments.
Lucey’s points of inquiry–although not discussed in this article–are particularly important when considered in conjunction with the joint U.S./Chinese program to investigate bat-borne coronaviruses, a program whose American funding apparatus involved USAID, a frequent front for CIA operations.
The gain of function experiments we discussed in FTR #‘s 1116, 1117 and 1121 involving adapting the H5N1 avian flu virus to ferrets is worth contemplating in the context of information indicating that the SARS Cov‑2 virus is particularly infective for ferrets.
Was part of the modified H5N1 flu virus adapted to SARS Cov‑2?
Another subject worth contemplating concerns Gilead Sciences, Tamiflu and the prognostications concerning a “twindemic” this fall, with influenza and Covid-19 combining to overwhelm the health system.
Might we see an enhanced H5N1 avian influenza this fall, providing enormous profits to Gilead Sciences, which, as we saw in FTR #1138, made an enormous amount of money (for itself and former Chairman of the Board Donald Rumsfeld) developing Tamiflu to negate the possibility of an H5N1 pandemic?
A key factor spurring our suspicion concerning genetic-engineering of one or more variant of the Covid-19 virus concerns a 2015 Gain-of-Function experiment performed by Ralph Baric, employed in a joint U.S./Chinese experiment partly financed by USAID (a front for CIA activity in the past) and NIH (used by both CIA and the Pentagon in the past). In that project, Baric: ” . . . . published a study on his team’s efforts to engineer a virus with the surface protein of the SHC014 coronavirus, found in horseshoe bats in China, and the backbone of one that causes human-like severe acute respiratory syndrome (SARS) in mice. The hybrid virus could infect human airway cells and caused disease in mice. . . . The results demonstrate the ability of the SHC014 surface protein to bind and infect human cells, validating concerns that this virus—or other coronaviruses found in bat species—may be capable of making the leap to people without first evolving in an intermediate host . . .”
Of more than passing interest is the disclosure that the project on bat-borne coronaviruses conducted in the Wuhan laboratory was a joint U.S./Chinese project, and that Ralph Baric was a key American partner in the project.
This is the undertaking about which we have reported and discussed extensively in the past! ” . . . . One of Dr Shi’s co-authors on that paper, Professor Ralph Baric from North Carolina University, said in an interview with ‘Science Daily’ at the time: ‘This virus is highly pathogenic and treatments developed against the original SARS virus in 2002 and the ZMapp drugs used to fight ebola fail to neutralise and control this particular virus.’ . . . .”
Reflections on “Epidemic Prevention” and “Vaccine Development”
In past programs, we have briefly noted that military and [ostensibly] civilian programs officially involved with “epidemic prevention” might conceal clandestine biological warfare applications designed to create epidemics. The official distinction between “offensive” and “defensive” biological warfare research is academic. Noteworthy in that general context is the observation by Jonathan King (professor of molecular biology at MIT), that Pentagon research into the application of genetic engineering to biological warfare could be masked as vaccine research, which sounds “defensive.” In FTR #1130, we noted the role of four-star general Gustave Perna in Trump’s “Operation Warp Speed,” instituted by General Mark Milley, Chairman of the Joint Chiefs of Staff. Whether the program serves as cover for military research seems a reasonable question to ask, under the circumstances. One should note that the official title of Unit 731, the notorious Japanese biological warfare unit was “the Epidemic Prevention and Water Purification Department of the Kwantung Army.”
FTR #1139 The Anthrax Attacks, the Invasion of Iraq and Expansion of Biological Warfare Capabilities
As the title indicates, this program presents political and historical foundation for the exponential expansion of American biological warfare infrastructure following the 2001 anthrax attacks.
Important background information comes from the Whitney Webb article about DARPA spending on bat-borne coronaviruses.
The Broadcasting Board of Governors–a CIA “derivative”–and The Washington Times (owned by the Unification Church) helped develop disinformation about SARS CoV‑2 coming from a Chinese Biological Warfare lab. Both were instrumental in hyping the anthrax attacks as authored by Saddam Hussein, as well. The Washington Times also presented information floated by Steven Hatfill that foreshadowed subsequent charges that Saddam Hussein was developing bioweapons and was behind the 2001 anthrax attacks.
In addition, the Project For a New American Century was advancing an agenda in which genetically-engineered biological warfare technology as essential to continued American global dominance.
As will be seen below, a key functionary in the PNAC milieu was former Secretary of Defense Donald Rumsfeld, former chairman of the board of Gilead Sciences.
In FTR #‘s 1135, 1136 and 1137, we relied heavily on the Kris Newby’s Bitten: The Secret History of Lyme Disease and Biological Weapons. In that book, Ms. Newby networked with a group of experienced, Cold War biological warfare professionals whom she termed “the Brain Trust.” They were convinced that Fort Detrick scientist Bruce Ivins–the “lone nut” who conveniently committed suicide and was fingered as the sole perpetrator of the 2001 anthrax attacks–was framed. ” . . . . Among other subjects, they discussed . . . technical details on why they believed that their colleague Bruce Ivins had been framed as the anthrax mailer . . . .”
Much of the program centers on the 2001 attacks and the suspicion that focused on Steven Hatfill as a possible perpetrator of them. Although exonerated in the attacks, Hatfill was the focal point of considerable suspicion in connection with the event. Our suspicion is that he is an operative of one or another intelligence agency, CIA being the most probable.
We suspect that the anthrax attacks were a provocation aimed at justifying the invasion of Iraq and spurring development of the U.S. biological warfare capability.
Of particular note is the apparent “operational Teflon” worn by Hatfill. Although circumstantial evidence pointed in his direction, he appeared to be altogether “off limits” to investigative elements of Alphabet Soup. Don Foster noted the unusual treatment accorded to Hatfill by the powers that be.
Of significance, as well, are the numerous examples of foreshadowing of the forensic circumstances of the anthrax attacks, as well as other “false alarm” incidents that occurred before and after the fatal attacks. It requires little to see statements and articles by notables such as Bill Patrick and the seemingly ubiquitous Steven Hatfill as laying a foundation of credibility for subsequent events.
Note that the National Institutes of Health have also partnered with CIA and the Pentagon, as underscored by an article about a BSL‑4 lab at Boston University.
1.–As the article notes, as of 2007, the U.S. had “more than a dozen” BSL4 labs–China commissioned its first as of 2017. a tenfold increase in funding for BSL4 labs occurred because of the anthrax attacks of 2001. Those attacks might be seen as something of a provocation, spurring a dramatic increase in “dual use” biowarfare research, under the cover of “legitimate” medical/scientific research. In FTR #1128, we hypothesized about the milieu of Steven Hatfill and apartheid-linked interests as possible authors of a vectoring of New York City with Sars COV2: ” . . . . Before the anthrax mailings of 2001, the United States had just two BSL4 labs—both within the razor-wire confines of government-owned campuses. Now, thanks to a tenfold increase in funding—from $200 million in 2001 to $2 billion in 2006—more than a dozen such facilities can be found at universities and private companies across the country. . . .”
2.–The Boston University lab exemplifies the Pentagon and CIA presence in BSL‑4 facility “dual use”: ” . . . . But some scientists say that argument obscures the true purpose of the current biodefense boom: to study potential biological weapons. ‘The university portrays it as an emerging infectious disease lab,’ says David Ozonoff, a Boston University epidemiologist whose office is right across the street from the new BSL4 facility. ‘But they are talking about studying things like small pox and inhalation anthrax, which pose no public health threat other than as bioweapons.’ . . . The original NIH mandate for the lab indicated that many groups—including the CIA and Department of Defense—would be allowed to use the lab for their own research, the nature of which BU might have little control over. . . .”
As noted in past programs, Gilead Sciences is very well-connected professionally, with former Secretary of Defense Donald Rumsfeld (among other political luminaries) serving on its board of directors. Rumsfeld was chairman of the board from 1997 until he left in 2001 to become George W. Bush’s Secretary of Defense.
Rumsfeld was Secretary of Defense during the period in which the 2001 anthrax attacks occurred.
During the post‑9/11 period of exploding government investments in biodefense programs, Secretary of Defense Donald Rumsfeld was still holding onto massive amounts of Gilead stock, which was increasing in value dramatically. What kind of relationship did Gilead develop with the US biodefense national security state during this period? That seems like a pretty important question at this point in time.
The U.S. government was among the customers whose purchases drove up the Gilead earnings and stock price: ” . . . . What’s more, the federal government is emerging as one of the world’s biggest customers for Tamiflu. In July, the Pentagon ordered $58 million worth of the treatment for U.S. troops around the world, and Congress is considering a multi-billion dollar purchase. . . .”
Several years into his tenure at the Pentagon, Rumsfeld made a killing on the sale of Gilead Sciences’ stock, which rose exponentially in value following its development of Tamiflu as a treatment for H5N1 avian flu.” . . . . The firm made a loss in 2003, the year before concern about bird flu started. Then revenues from Tamiflu almost quadrupled, to $44.6m, helping put the company well into the black. Sales almost quadrupled again, to $161.6m last year. During this time the share price trebled. Mr Rumsfeld sold some of his Gilead shares in 2004 reaping – according to the financial disclosure report he is required to make each year – capital gains of more than $5m. The report showed that he still had up to $25m-worth of shares at the end of 2004, and at least one analyst believes his stake has grown well beyond that figure, as the share price has soared. . . .”
Donald Rumsfeld was a signatory to the 1998 letter to President Clinton by the Project for a New American Century. That letter advocated a harder line against Iraq. ” . . . . Rumsfeld has strong ties to the Intelligence Community, as well as to the Atlantic Institute, and is a member of the Bilderberg group. He is a financial supporter for the Center for Security Policy. Rumsfeld was one of the signers of the January 26, 1998, Project for the New American Century (PNAC) letter sent to President William Jefferson Clinton. . . .”
DARPA and the Pentagon have into the application of genetic engineering in order to create ethno-specific biological warfare weapons, as discussed by the Project for a New American Century.
In past programs and posts, we have noted that DARPA was researching bat-borne coronaviruses. One can but wonder to what extent the PNAC doctrine helped spawn the DARPA research into coronaviruses and, possibly, the Covid-19 pandemic.
FTR #1138 Bio-Psy-Op Apocalypse Now, Part 10: Bad Medicine
Continuing discussion about drug treatments for, and vaccines to prevent, Covid-19, this program sets forth information about the ongoing professional massaging of Gilead Sciences’ anti-viral remdesivir. Only modestly successful against SARS Cov‑2 (the virus that causes Covid-19), remdesivir has been propelled to the forefront of treatment regimens for the pandemic.
Of particular interest are the circumstances surrounding the CDC’s closure of the U.S. Army Medical Research Institute of Infectious Diseases. The USAMRIID–located at Ft. Detrick–had hosted Gilead Sciences’ animal trials of remdesivir. Remdesivir was developed to combat Ebola, and was a failure in its initial professional iteration.
In March of 2019, rhesus macaques were infected with Ebola at the USAMRIID as part of a project to allow remdesivir to be marketed as an Ebola treatment without meeting the professional standards of human testing. ” . . . This agreement was made possible through a 2018 Natural History Study (NHS) of Ebola virus conducted by USAMRIID in close collaboration with Gilead Sciences, Inc., the sponsor of remdesivir development . . .”
Many of the safety violations cited by the CDC in its critique of USAMRIID safety and security procedures concerned “non-human primates” infected with one or more “select agents” that were not named. The term “select agent” refers to a pathogen being used in laboratory procedures. Whether the “select agent” was Ebola, and whether the safety lapses were in connection with the remdesivir/rhesus monkey trials was not disclosed.
” . . . . Several of the laboratory violations the CDC noted in 2019 concerned ‘non-human primates’ infected with a ‘select agent’, the identity of which is unknown — it was redacted in all received documents, because disclosing the identity and location of the agent would endanger public health or safety, the agency says. In addition to Ebola, the lab works with other deadly agents like anthrax and smallpox. . . ..”
If, for the sake of argument, SARS-CoV‑2 research was indeed taking placing there was a very real risk of it escaping.
Remdesivir failed in its human trials as a treatment for Ebola: ” . . . . The antiviral drug remdesivir, made by Gilead, underperformed ZMapp. . . . Remdesivir and ZMapp have been dropped from the trial. . . .”
Following that dismal performance against Ebola, Gilead Sciences recast remdesivir as a broad spectrum antiviral, a marketing approach that has led to the drug being authorized to treat Covid-19.
In that professional reincarnation, it demonstrated altogether modest success in Covid-19 trials that were professionally criticized and which were badly skewed from a methodological standpoint.
After a tightening of professional methodological standards at the USAMRIID, it was disclosed that most of the institution’s operatives are private contractors! From the standpoint of institutional security, the broad use of private contractors renders USAMRIID subject to penetration by any number of potential miscreants. ” . . . . ‘A majority of our laboratory workers are contractors–putting teeth in the contracts to ensure they’re following the shalls, wills and musts are things we’ve done in the interim,’ said [Brigadier General Mike] Talley. . . .”
As noted in past programs, Gilead Sciences is very well-connected professionally, with former Secretary of Defense Donald Rumsfeld (among other political luminaries) serving on its board of directors. Rumsfeld was chairman of the board from 1997 until he left in 2001 to become George W. Bush’s Secretary of Defense. The firm’s stock has been heavily invested in by hedge funds, including Robert Mercer’s Renaissance Technologies. Gilead Sciences’ stock has been a major driver of the stock market’s performance.
Several years into his tenure at the Pentagon, Rumsfeld made a killing on the sale of Gilead Sciences’ stock, which rose exponentially in value following its development of Tamiflu as a treatment for H5N1 avian flu. ” . . . . The firm made a loss in 2003, the year before concern about bird flu started. Then revenues from Tamiflu almost quadrupled, to $44.6m, helping put the company well into the black. Sales almost quadrupled again, to $161.6m last year. During this time the share price trebled. Mr Rumsfeld sold some of his Gilead shares in 2004 reaping – according to the financial disclosure report he is required to make each year – capital gains of more than $5m. The report showed that he still had up to $25m-worth of shares at the end of 2004, and at least one analyst believes his stake has grown well beyond that figure, as the share price has soared. . . .”
The U.S. government was among the customers whose purchases drove up the Gilead earnings and stock price: ” . . . . What’s more, the federal government is emerging as one of the world’s biggest customers for Tamiflu. In July, the Pentagon ordered $58 million worth of the treatment for U.S. troops around the world, and Congress is considering a multi-billion dollar purchase. . . .”
(Recall that the H5N1 virus is one of the gain-of-function experiments that was suspended in 2014 and then greenlighted by the Trump administration in 2017. Those experiments engineered the virus to infect ferrets, a maneuver that made the virus communicable by upper respiratory activity. One can but wonder if those G‑O-F experiments were connected to the recasting of remdesivir as a broad spectrum antiviral.)
During the post‑9/11 period of exploding government investments in biodefense programs, Rumsfeld was still holding onto massive amounts of Gilead’s stock, which was rapidly increasing in value. What kind of relationship did Gilead develop with the US biodefense national security state during this period? That seems like an important question at this point in time.
In FTR #1136, we noted that the medical and scientific interests in charge of Lyme Disease treatment and diagnosis were not only financial beneficiaries of the therapeutic status quo, but were also tasked with discrediting Lyme patients and physicians who challenged that status quo. In light of the evidence that Lyme Disease was the outgrowth of biological warfare research, the professional relationship between governmental institutions involved with BW research and biotechnology and pharmaceutical firms profiting from the treatment of diseases those institutions develop and deploy is worth contemplating!
Previous broadcasts have documented the skewed, preferential treatment of remdesivir by powerful political and financial players with significant investment in the success of remdesivir.
The program concludes with three updates of previous lines of inquiry”
1.–Past programs have highlighted possible vectors into Wuhan for the SARS CoV‑2. We note that there was a workshop held at the Wuhan lab in early November of 2019, featuring scientists and bio-lab professionals from around the world. This conference may have been among the opportunities to spread the virus, and/or a co-vector and/or cross-vector. ” . . . . The workshop is designed for laboratory managers and directors, research and laboratory staffs mainly from developing countries who plan to carry out infectious disease research in biosafety facilities. The workshop will address key aspects of biosafety and provide practical training in high level biosafety laboratories (BSL). This workshop will invite a group of well-known scholars and experts from related fields at home and abroad to provide the theoretical and practical courses. . . .”
2.–As noted in past programs the Wuhan Institute of Virology was engaged in bat-borne coronavirus research, which included the genetic modification of such organisms. That research was a joint U.S./Chinese undertaking, with the U.S. funding coming from institutions which have fronted for American intelligence and the Pentagon. That joint U.S./Chinese undertaking was terminated by the Trump administration in May! In addition: ” . . . . Many of the scientists at the Wuhan Institute of Virology have been trained by the U.S. government’s PREDICT project. . . . USAID’s PREDICT project . . . will end this September after 10 years and two six-month extensions as USAID launches a new project that applies the data PREDICT collected. . . .”
3.–Other broadcasts have explored the Wuhan World Military Games–a military sports competition–as a possible vectoring vehicle. We update that path of inquiry with discussion of the U.S. delegation as a possible vectoring agent for the spread of the disease in the U.S. ” . . . . Contrary to the Pentagon’s insistence, however, an investigation of COVID-19 cases in the military from official and public source materials shows that a strong correlation exists in COVID-19 cases reported at U.S. military facilities that are home bases of members of the U.S. team that went to Wuhan. Before March 31, when the Pentagon restricted the release of information about COVID-19 cases at installations for security reasons, infections occurred at a minimum of 63 military facilities where team members returned after the Wuhan games. Additionally, the U.S. team used chartered flights to and from the games via Seattle-Tacoma International Airport. Washington was one of the earliest states to show a spike in COVID-19. . . .” We also note that the U.S. delegation contained: ” . . . . nine public-affairs officers . . . and two State Department personnel, according to DOD documents. . . .” “Public affairs officer” is a common cover for CIA personnel.
FTR #1137 Lyme Disease and Biological Warfare, Part 3
Further developing the links between biological warfare research and the Lyme Disease establishment, we review information from FTR #585.
At every turn, Lyme disease research is inextricably linked with biological warfare research. Divided into the “Steere” and “ILADS” camps, the Lyme disease research community is split between the view that the disease is “hard-to-catch, easy-to-cure” and the diametrically opposed view that the disease is very serious and produces long-term neurological disorder. The Steere camp diminishes the significance of the disease and is closely identified with biological warfare research. At the epicenter of Lyme disease research (and the Steere camp) are members of the Epidemic Intelligence Service, or EIS. EIS personnel are to be found at every bend in the road of Lyme disease research.
The Borrelia genus has long been researched as a biological warfare vector. Note that Unit 731 personnel and their files were put to work for the United States after World War II, much like the Project Paperclip scientists from Germany. ” . . . borrelia were known for their ability to adopt different forms under conditions of stress (such as exposure to antibiotics). Shedding their outer wall, (which is the target of penicillin and related drugs), they could ward off attack and continue to exist in the body. . .”
Much of the program is devoted to excerpting and analysis of a 2013 posting by Elena Cook. This discussion of “Spirochete Warfare,” in turn, makes liberal use of material from a 1944 text about Japan’s biological warfare program. This book “Japan’s Secret Weapon,” contains a great deal of information about Japanese pioneering of the use of spirochetes as biological warfare organisms.
This material is to be considered in the historical and political context of the incorporation of the key personnel and files of the notorious Japanese Unit 731 biological warfare division into the U.S. BW program after World War II.
Apparently decades ahead of their Allied counterparts, Japanese use of spirochetes encompassed a number of important points to consider.
1.–The Japanese understood that “cell-wall deficient spirochetes, ” “granule” and “L‑forms” had tremendous significance for biological warfare. ” . . . This WW2-era book helps to confirm what some investigating the history of Lyme disease have long suspected; that the official denial of the devastating pathogenic nature of the granule and other ‘L‑forms’(1) of Lyme-causing Borrelia, is related to their biological warfare significance. . .”
2.–” . . . To put it bluntly, Newman’s book provides cogent circumstantial evidence that many Cell-wall deficient forms of Borrelia are in fact weaponized spirochetes, nurtured, cultured and optimized for aerosol delivery. . .”
3.–According to author Barclay Newman, a combined Japanese and Nazi biological warfare offensive against Hawaii using the spirochetal disease leptospirosis against Hawaii two or three years before the attack on Pearl Harbor: ” . . . . ‘Nazi and Japanese scientists cooperated in warfare against or with spirochetes — in Hawaii.’ (original author’s italics). What he is referring to is an exceptionally virulent outbreak of the spirochetal disease leptospirosis, also known as Weil’s disease, and known at the time in Germany as ‘slime fever’. With official reports of 44% mortality from the outbreak, Newman states: Consult the authorities, and you will find out that, very definitely, so high a mortality is attained only by Japanese strains of spirochetes of slime fever. . . .”
4.–According to Newman, the Japanese had concluded that spirochetes, although very close to bacteria in form, were not actually bacteria and therefore: ” . . . . a spirochete can also break itself into many tiny granules, each as small as the invisible molecule of a virus, and each capable of recreating a new spirochete. . . .”
5.–Again, according to Newman: ” . . . The Japanese have reported that you can increase the virulence, or killing power, of these spirals by growing them in flesh and blood, of guinea pig or man. . .” This is interesting to consider in light of the evidence of Lyme Disease as the product of biological warfare. Might some of the “tests” have had the goal of “growing” such organisms in humans? ” . . . The resistance of many spirochetes, including borrelia, to culture in vitro remains a problem for lab scientists even today. . .”
6.–The “granule” spirochete form was found by the Japanese to have great value for aerosolized BW applications: ” . . . Inada has reported that the Japanese know how to get virus-like, quite invisible particles or spirochete-fragments from special cultures of spirochetes of infectious jaundice. The Japanese say that such infinitesimals can be used to infect animals and men, by spraying droplets containing these spirochete-creating bits into the air, or spreading them through water, or scattering them in mud or damp soil. . . .”
7.–The above-mentioned leptospirosis or “slime fever” may have been used as a “softening-up” agent prior to Japanese invasions in World War II” ” . . . ‘Immediately before the Japanese invasions of China, Indo-China, the Dutch East Indies, and the Malay States, and shortly before the Japanese invasion of India and the Japanese strokes at Australia, the very first outbreaks of slime fever were reported from every one of these areas’ . . .”
8.–The Japanese had discovered the application of infection via multiple pathogens. This may have figured into the development of Lyme Disease as well. ” . . . Fujimori (sic) was testing out the effects of spreading two different parasites into the same guinea pig at the same time. The Japanese discovered that one parasite promotes the lethal action of the other. . . .”
9.–The Japanese developed with spreading spirochetal disease via spraying droplets into the eyes of targets. We wonder if Willy Burgdorfer’s possible Lyme infection from diseased Rabbit-urine may have stemmed from this technology? This is discussed below. ” . . . ‘Sometimes the Japanese think up the damnedest experiments, such as the transmission of syphilis by spraying the spirochetes into the air or into the eyes of animals or volunteers. Infection is thus accomplished. . . . if you want to speculate further about the possibilities of spirochete warfare, you can be sure that the Japanese know how to spread any spirochete disease . . . by spraying droplets laden with specially cultured spirochetes. . . .”
10.-Among the diseases apparently harnessed for BW use by the Japanese was African relapsing fever. Willy Burgdorfer did his graduate thesis about this tick-borne spirochetal disease and it was researched at length by his mentor Rudolf Geigy. (Geigy’s possible role as an I.G. Farben intelligence agent and Paperclip recruiter is discussed in FTR #1135. Note that some forms of Borrelia Burgdorferi–a primary causative agent of Lyme Disease–resemble the spirochete that causes relapsing fever. ” . . . Relapsing fever is caused by the Borrelia genus of bacteria, and is generally transmitted to man either by lice, or by the bite of a tick. It is worth noting, too, that recent investigations into the genetic make-up of Lyme borrelia have found some strains apparently more closely related to relapsing fever Borrelia than to Borrelia burgdorferi, long considered the only borrelia capable of causing Lyme disease. . . .”
Next, the program details Rudolf Geigy’s work on relapsing fever. We suspect that his interest in such afflictions was not as benign and altruistic as his defenders maintain. As mentioned above, Lyme Disease “discoverer” and biological warfare veteran Willy Burgdorfer did his graduate thesis on relapsing fever.
Again, as mentioned above, Willy Burgdorfer contracted what he felt was Lyme Disease after urine from an infected rabbit splashed into his eyes. We wonder if some of the techniques of using aerosolized spirochete granules might have been involved in Willy’s accidental infection? ” . . . .While he was rinsing off one of the trays in the sink, Lyme-infected rabbit urine splashed into his eyes. A few weeks later, on April 13, he noticed five Lyme bull’s-eye rashes under his armpit and on his torso. . . .”
In an unpublished manuscript, Willy Burgdorfer noted not only the persistence of Lyme Disease but its ability to remain dormant in the nervous system: “. . . . It is now clear that Borrelia burgdorferi can persist within the nervous system for years, causing progressive illness, and increasing evidence suggests also that the spirochete can remain latent there for years before producing clinical symptoms. . . .”
Lyme disease is difficult to diagnose, another factor that makes it ideal for BW use. Might the Japanese Unit 731 research into spirochetal warfare described by Barclay Newman have figured into some of the boiler-plate research that went into the development of Lyme Disease? ” . . . Lyme’s ability to evade detection on routine medical tests, its myriad presentations which can baffle doctors by mimicking 100 different diseases, its amazing abilities to evade the immune system and antibiotic treatment, would make it an attractive choice to bioweaponeers looking for an incapacitating agent. Lyme’s abilities as ‘the great imitator’ might mean that an attack could be misinterpreted as simply a rise in the incidence of different, naturally-occurring diseases. . . .”
There is experimental evidence that infection with Borrelia burgdorferi can produce the amyloid plaques symptomatic of Alzheimer’s Disease. ” . . . Here is hypothesized a truly revolutionary notion that rounded cystic forms of Borrelia burgdorferi are the root cause of the rounded structures called plaques in the Alzheimer brain. Rounded “plaques’ in high density in brain tissue are emblematic of Alzheimer’s disease (AD). . . .”
The program concludes with more experimental evidence of the production of amyloid deposits characteristic of Alzheimer’s Disease: ” . . . To determine whether an analogous host reaction to that occurring in AD could be induced by infectious agents, we exposed mammalian glial and neuronal cells in vitro to Borrelia burgdorferi spirochetes . . . Morphological changes analogous to the amyloid deposits of AD brain were observed following 2–8 weeks of exposure to the spirochetes. . . These observations indicate that, by exposure to bacteria or to their toxic products, host responses similar in nature to those observed in AD may be induced. . . .”
FTR #1136 Lyme Disease and Biological Warfare, Part 2
A recent book about Lyme Disease sets forth credible information that the disease is an outgrowth of U.S. biological warfare research.
Bitten, The Secret History of Lyme Disease and Biological Weapons chronicles the career of Willy Burgdorfer, a Swiss-born expert on tick and flea-borne diseases who spent most of his career researching those areas as a U.S. biological warfare scientist.
” . . . . if Willy’s claim was true, a crime against humanity had been committed by the U.S. government, and then covered up. . . ” “Bitten,” p. 103.
Listeners are emphatically encouraged to purchase and read this book, as well as sharing it with others.
Author Kris Newby presents substantive evidence that the disease stems from BW research done by Burgdorfer and associates. (Burgdorfer was the scientist who “discovered” the organism that causes Lyme Disease.)
NB: The material in this broadcast is deliberately overlapped with that in the last program.
In this post, we highlight information about what Willy termed “the Swiss Agent”–a rickettsia that was present in the vast majority of Lyme sufferers tested early in research into the disease.
Eventually, discussion of the possible role of Swiss Agent dropped out of discussion. The disappearance of the Swiss Agent from the scientific analytical literature coincided with Willy’s telephone conversations with biological warfare research veterans.
Key points of discussion:
1.–” . . . . I would engage the scientific part of his brain in answering my two questions: why the Lyme discovery files were missing from the National Archives, and why images of the organism labeled ‘Swiss Agent’ were located in the archive folders in the time-frame where one would expect the Lyme spirochete pictures to be. . . .”
2.–” . . . . He told me that in late 1979, he had tested ‘over one hundred ticks’ from Shelter Island, located about twenty miles from the Lyme outbreak, and all but two had an unidentified rickettsial species inside. It looked like Rickettsia montana (now called Rickettsia montanensis) under a microscope, a non-disease-causing cousin of the deadly Rickettsia ricketsii, but it was a different species. . . .”
3.–” . . . .‘You say they’re not looking for it anymore?’ I asked. ‘They probably paid people off,’ he said. ‘There are folks up there who have a way to enable that.’ . . .”
4.–” . . . . Next, I showed Willy an unlabeled image of a microbe and asked him what it was. ‘That is a Swiss Agent,’ said Willy. I asked him a series of questions on this microbe and he recited what seemed like well-rehearsed lines: the Swiss Agent is a Rickettsia montana-like organism found in the European sheep tick, Ixodes Ricinus, and it doesn’t cause disease in humans. . . .”
5.–” . . . . Then I asked him why he brought samples of it from Switzerland back to his lab. He replied with the response that he often used when he seemed to know the answer but wasn’t going to divulge it: ‘Question mark.’. . .”
6.–” . . . . The real ‘smoking gun,’ though, was Willy’s handwritten lab notes on the patient blood tests from the disease outbreak in Connecticut. These tests showed the proof-of-presence of what I named ‘Swiss Agent USA,’ the mystery rickettsia present in most of the patients from the original Lyme outbreak, a fact that was never disclosed in journal articles. It didn’t take a PhD in microbiology to see that almost all the patient blood had reacted strongly to an antigen test for a European rickettsia that Willy had called the Swiss Agent. . . .”
7.–” . . . . In March, he wrote to Anderson and Steere again: ‘Most specimens, with a few exceptions, reacted only against antigens prepared from the Swiss Agent.’ In short, the disease clusters in Connecticut and Long Island seemed to have been caused by Swiss Agent USA. Then, in April, the Swiss Agent USA rickettsia vanished. It was never again mentioned in talks, letters, interviews, or journal articles. . . . There is, without a doubt, something suspicious about the sudden disappearance of the Swiss Agent USA from all correspondence. . . .”
8.–The disappearance of the Swiss Agent USA from the literature on Lyme Disease corresponded with an important conversation that Willy had: ” . . . . It was in the beginning of 1980—two years before the first Lyme spirochetes were found—that the Swiss Agent USA disappeared. This about-face coincided with a series of discussions Willy had with old bioweapons developers on the Rickettsial Commission of the Armed Forces Epidemiological Board, as recorded in his personal phone log. These scientists were most certainly familiar with the secret history of incapacitating rickettsial and viral agent testing, and they may have discussed with Willy the possibility of there having been an undisclosed field test in the Long Island region. . . .”
9.–Roundworms similar to organisms studied by Willy at the Naval Research Unit in Cairo turned up in some of the ticks: ” . . . . That’s when Willy found parasitic roundworm larvae in the main body cavity of two of the ticks. They were similar to the deer worms he’d found in ticks on his 1978 trip to Switzerland, and similar to the roundworms that he, Sonenshine, and the Naval Research Unit in Cairo had worked with for a project exploring the ‘relatively new field of endo-parasitic transmission of disease agents.’ In these experiments, multiple disease agents were put inside mosquito-borne roundworms, according to an NIH research report from 1961. . . .”
10.–Numerically, it appears that the Swiss Agent rickettsias outnumbered the spirochetes that ultimately were tabbed as the causative agent for Lyme Disease: ” . . . . When Willy dissected 124 more Shelter Island deer ticks, 98 percent had the new rickettsias in them and only 60 percent carried the new spirochetes. Willy thought that either microbe might be causing Lyme disease, but, for unknown reasons, this alternative theory fell into a black hole. . . .”
Pivoting to discussion of the politics of Lyme Disease treatment, we note that legal and regulatory rulings have enabled the patenting of living organisms and that has exacerbated the monetizing of Lyme Disease treatment. That monetization, in turn, has adversely affected the quality of care for afflicted patients. As we will see later, Willy Burgdorfer was not the only Lyme Disease researcher to become involved with biological warfare research. ” . . . . All of a sudden, the institutions that were supposed to be protectors of public health became business partners with Big Pharma. The university researchers who had previously shared information on dangerous emerging diseases were now delaying publishing their findings so they could become entrepreneurs and profit from patents through their university technology transfer groups. We essentially lost our system of scientific checks and balances. And this, in turn, has undermined patient trust in the institutions that are supposed to ‘do no harm.’ . . .”
Ms. Newby went up against the “Lyme Disease establishment” in an attempt to find out why the disease was being mis-diagnosed and ineffectively treated. Strikingly, a FOIA suit she filed was stonewalled for five years, before finally yielding the documents she had so long sought.
The “experts” and their agenda was neatly, and alarmingly, summed up by Ms. Newby: ” . . . . The emails revealed a disturbing picture of a nonofficial group of government employees and guidelines authors that had been setting the national Lyme disease research agenda without public oversight or transparency. . . . Bottom line, the guidelines authors regularly convened in government-funded, closed-door meetings with hidden agendas that lined the pockets of academic researchers with significant commercial interests in Lyme disease tests and vaccines. A large percentage of government grants were awarded to the guideline authors and/or researchers in their labs. Part of the group’s stated mission, culled from these FOIA emails, was to run a covert ‘disinformation war’ and a ‘sociopolitical offensive’ to discredit Lyme patients, physicians, and journalists who questioned the group’s research and motives. In the FOIA-obtained emails, Lyme patients and their treating physicians were called ‘loonies’ and ‘quacks’ by Lyme guidelines authors and NIH employees. . . .”
Further developing the links between biological warfare research and the Lyme Disease establishment, we review information from FTR #585.
At every turn, Lyme disease research is inextricably linked with biological warfare research. Divided into the “Steere” and “ILADS” camps, the Lyme disease research community is split between the view that the disease is “hard-to-catch, easy-to-cure” and the diametrically opposed view that the disease is very serious and produces long-term neurological disorder. The Steere camp diminishes the significance of the disease and is closely identified with biological warfare research. At the epicenter of Lyme disease research (and the Steere camp) are members of the Epidemic Intelligence Service, or EIS. EIS personnel are to be found at every bend in the road of Lyme disease research.
The Borrelia genus has long been researched as a biological warfare vector.
” . . . . The Borrelia genus of bacteria, which encompasses the Borrelia burgdorferi species-group (to which Lyme disease is attributed), was studied by the infamous WW2 Japanese biowar Unit 731, who carried out horrific experiments on prisoners in Manchuria, including dissection of live human beings. [iii] Unit 731 also worked on a number of other tick-borne pathogens. . . . . borrelia were known for their ability to adopt different forms under conditions of stress (such as exposure to antibiotics). Shedding their outer wall, (which is the target of penicillin and related drugs), they could ward off attack and continue to exist in the body. . . .”
Note that Unit 731 personnel and their files were put to work for the United States after World War II, much like the Project Paperclip scientists from Germany.
FTR #‘s 1135, Lyme Disease and Biological Warfare, Part 1
” . . . . if Willy’s claim was true, a crime against humanity had been committed by the U.S. government, and then covered up. . . ” Bitten, p. 103.
A recent book about Lyme Disease sets forth credible information that the disease is an outgrowth of U.S. biological warfare research.
Bitten, The Secret History of Lyme Disease and Biological Weapons chronicles the career of Willy Burgdorfer, a Swiss-born expert on tick and flea-borne diseases who spent most of his career researching those areas as a U.S. biological warfare scientist.
Author Kris Newby presents substantive evidence that the disease stems from BW research done by Burgdorfer and associates. (Burgdorfer was the scientist who “discovered” the organism that causes Lyme Disease.)
In past discussion of Lyme Disease, we have explored the incorporation of Nazi scientists via Operation Paperclip into the American biological warfare program and possible links between their work and the spread of the disease in Connecticut, across Long Island Sound from Plum Island.
(FTR #‘s 480 and 585 highlight discussion about Lyme Disease and biological warfare.)
Burgdorfer’s entree into the American biological warfare program resulted from his professional relationship with long time mentor and patron Rudolf Geigy. Geigy belonged to a family whose business, J.R. Geigy AG, was a Swiss chemical firm marketing dyes and insecticides.
Significantly, J.R. Geigy, Ciba and Sandoz comprised a Swiss chemical cartel formed in the aftermath of World War I to compete with the I.G. Farben cartel.
(Today, the three companies have coalesced as the Swiss pharmaceutical giant Novartis.)
Eventually, the Swiss consortium was absorbed into, and became a key component of, the I.G. Farben cartel. They readily collaborated with the Third Reich:
1.–” . . . . The chapters on Switzerland’s chemical industry are the most embarrassing section of the commission’s report. It is now clear that the directors of Swiss companies in Basel were very well aware what was going on at the time in Germany and had knowledge of the coerced employment of forced laborers in their branch plants in Germany as well as of the fact that forced laborers died as a result of the conditions in which they were held. . . .”
2.–” . . . . several leading Swiss chemical firms — including JR Geigy, Ciba, Sandoz and Hoffmann-La Roche — put their own interests ahead of humanitarian concerns in their dealing with the Nazis. . . .”
3.–” . . . .The ICE [Independent Commission of Experts] concluded that the chemical firms’ bosses in Switzerland ‘possessed a high level of detailed knowledge about the political and economic situation in Nazi Germany... [and] incorporated their knowledge... into their economic planning and used it as a basis for decision-making’ . . . .”
4.–” . . . . ‘Geigy maintained particularly good relations with Claus Ungewitter, the Reich commissioner for chemicals.’ . . .”
5.–” . . . . During the war, it [Geigy] produced insecticides and, most notably, the iconic ‘polar red’ dye that colored the background of Nazi swastika flags. . . .”
All three Swiss firms [Geigy, Sandoz and Ciba] were indicted in the United States in 1942 because of their collaboration with I.G. Farben and the Third Reich.
1.–” . . . . Those indicted included duPont; Allied Chemical and Dye; and American Cyanamid; also Farben affiliates the American Ciba, Sandoz and Geigy. . . .”
2.–” . . . . A long list of other co-conspirators included the Swiss Ciba, Sandoz and Geigy companies with Cincinnati Chemical works, their jointly owned American concern . . . .”
3.–” . . . . When Secretary of War Stimson and Attorney General Biddle agreed to postpone the trial until it would not interfere with war production, one Justice Department official was quoted as saying sourly, ‘First they hurt the war effort by their restrictive practices, and then if caught they use the war effort as an excuse to avoid prosecution.’ . . .”
Useful background research with which to flesh out understanding of the titillating information presented by Ms. Newby concerning Geigy and his activities can be obtained by reading some of the many books available for download on this website.
Numerous programs present research on the topic, including FTR #511.
A key foundational element for the discussion of Bitten is the Pentagon’s decades-long research into the genetic manipulation of microbial pathogens.
1.–Nobel Prize winner Joshua Lederberg warned of the consequences for humanity of this work: ” . . . .‘The large-scale deployment of infectious agents is a potential threat against the whole species: mutant forms of viruses could well develop that would spread over the earth’s population for a new Black Death,’ said Lederberg in a Washington Post editorial on September 24, 1966. He added, ‘The future of the species is very much bound up with the control of these weapons. Their use must be regulated by the most thoughtful reconsideration of U.S. and world policy.’ . . .”
2.–The Pentagon was dismissive of the warning: ” . . . . A month later, the army’s Biological Subcommittee Munitions Advisory Group thumbed its nose at this ‘national pronouncement made by prominent scientists.’ . . . The advisory group then continued discussing its plans for genetic manipulation of microbes, new rickettsial and viral agents, and the development of a balanced program for both incapacitating and lethal agents. . . .”
3.–By 1962, the military’s plans for development of genetically modified microbes were developing in earnest. ” . . . . Fort Detrick’s director of biological research, Dr. J.R. Goodlow, on February 16, 1962 . . . added, ‘Studies of bacterial genetics are also in progress with the aim of transferring genetic determinants from one type of organism to another.‘The goal of these experiments was to make biological agents more virulent and resistant to antibiotics. . . .”
The Pentagon’s genetic manipulation of microorganisms for biological warfare purposes involved the Rocky Mountain Lab and Willy Burgdorfer.
1.–” . . . . Bioweapons researchers such as Willy knew that infecting large populations would require exposing people to agents for which they had no natural immunity. And to do this, researchers would have to import and/or invent new microbes. They were, in essence, playing God, creating ‘bacteriological freaks or mutants,’ by using chemicals, radiation, ultraviolet light, and other agents, wrote modern investigative journalism pioneer Jack Anderson in a Washington Post column on August 27, 1965. . . .”
2.–” . . . . Willy had already been conducting a trial-and-error style of genetic manipulation in the same way that a corn farmer or a hog grower selectively breeds strains that result in desired outcomes. He was growing microbes inside ticks, having the ticks feed on animals, and then harvesting the microbes from the animals that exhibited the level of illness the military had requested. . . .”
3.–” . . . . He was also simultaneously mixing bacteria and viruses inside ticks, leveraging the virus’s innate ability to manipulate bacterial genes in order to reproduce, and thus accelerating the rate of mutations and desirable new bacterial traits. In 1966, Fort Detrick’s Biological Subcommittee Munitions Advisory Group put this emerging research area at the top of its priorities, describing it as ‘Research in microbial genetics concerned with aspects of transformation, transduction, and recombination.’ . .”
Interviewed by an indie filmmaker named Tim Grey, Willy Burgdorfer discussed the development of Lyme Disease as a biological warfare weapon. It was Burgdorfer who “discovered” the spirochete that caused Lyme Disease in 1982. As we will see later, it appears that more than one organism is involved with Lyme Disease.
1.–” . . . . Willy paused, then replied, ‘Question: Has [sic] Borrelia Burgdorferi have the potential for biological warfare?’ As tears welled up in Willy’s eyes, he continued, ‘Looking at the data, it already has. If the organism stays within the system, you won’t even recognize what it is. In your lifespan, it can explode . . . We evaluated. You never deal with that [as a scientist]. You can sleep better.’ . . .”
2.–” . . . . Later in the video, Grey circled back to this topic and asked, ‘If there’s an emergence of a brand-new epidemic that has the tenets of all of those things that you put together, do you feel responsible for that?’ ‘Yeah. . . .’ ”
3.–” . . . . Grey asked him the one question, the only question, he really cared about: ‘Was the pathogen that you found in the tick that Allen Steere [the Lyme outbreak investigator] gave you the same pathogen or similar, or a generational mutation, of the one you published in the paper . . . the paper from 1952?’ ”
4.–” . . . . The left side of his mouth briefly curled up, as if he is thinking, ‘Oh, well.’ Then anger flashes across his face. ‘Yah,’ he said, more in German than English. . . .”
5.–” . . . . It was a stunning admission from one of the world’s foremost authorities on Lyme disease. If it was true, it meant that Willy had left out essential data from his scientific articles on the Lyme disease outbreak, and that as the disease spread like a wildfire in the Northeast and Great Lakes regions of the United States, he was part of the cover-up of the truth. . . It had been created in a military bioweapons lab for the specific purpose of harming human beings. . . . ”
To conclude the program, we highlight information about what Willy termed “the Swiss Agent”–a rickettsia that was present in the vast majority of Lyme sufferers tested early in research into the disease. Note that this element of analysis will be continued in our next program.
Eventually, discussion of the possible role of Swiss Agent dropped out of discussion. The disappearance of the Swiss Agent from the scientific analytical literature coincided with Willy’s telephone conversations with biological warfare research veterans.
Key points of discussion:
1.–” . . . . I would engage the scientific part of his brain in answering my two questions: why the Lyme discovery files were missing from the National Archives, and why images of the organism labeled ‘Swiss Agent’ were located in the archive folders in the time-frame where one would expect the Lyme spirochete pictures to be. . . .”
2.–” . . . . He told me that in late 1979, he had tested ‘over one hundred ticks’ from Shelter Island, located about twenty miles from the Lyme outbreak, and all but two had an unidentified rickettsial species inside. It looked like Rickettsia montana (now called Rickettsia montanensis) under a microscope, a non-disease-causing cousin of the deadly Rickettsia ricketsii, but it was a different species. . . .”
3.–” . . . .‘You say they’re not looking for it anymore?’ I asked. ‘They probably paid people off,’ he said. ‘There are folks up there who have a way to enable that.’ . . .”
4.–” . . . . Next, I showed Willy an unlabeled image of a microbe and asked him what it was. ‘That is a Swiss Agent,’ said Willy. I asked him a series of questions on this microbe and he recited what seemed like well-rehearsed lines: the Swiss Agent is a Rickettsia montana-like organism found in the European sheep tick, Ixodes Ricinus, and it doesn’t cause disease in humans. . . .”
5.–” . . . . Then I asked him why he brought samples of it from Switzerland back to his lab. He replied with the response that he often used when he seemed to know the answer but wasn’t going to divulge it: ‘Question mark.’. . .”
6.–” . . . . The real ‘smoking gun,’ though, was Willy’s handwritten lab notes on the patient blood tests from the disease outbreak in Connecticut. These tests showed the proof-of-presence of what I named ‘Swiss Agent USA,’ the mystery rickettsia present in most of the patients from the original Lyme outbreak, a fact that was never disclosed in journal articles. It didn’t take a PhD in microbiology to see that almost all the patient blood had reacted strongly to an antigen test for a European rickettsia that Willy had called the Swiss Agent. . . .”
Recommended Reading
- Spitfire List is licensed under Creative Commons.
Recent Comments